Ranking Member's Press

05.27.22

Senators Burr, Murray Introduce Bill to Support FDA Programs to Lower Costs and Spur Innovation

WASHINGTON, D.C. -Today, Senate Health, Education, Labor and Pensions (HELP) Committee Ranking Member Senator Richard Burr (R-NC), and Chair Senator Patty Murray (D-WA), introduced the FDA Safety and Landmark Advancements (FDASLA) Act-legislation reauthorizing the Food and Drug Administration's (FDA) prescription drug, generic drug, biosimilar, and medical device user fee agreements. The legislation also includes provisions to strengthen oversight of cosmetics and dietary supplements, modernize … Continue Reading


05.26.22

Burr: When Will the FDA Take Accountability for Failure on Infant Formula Crisis?

Today, the Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing titled, "Infant Formula Crisis: Addressing the Shortage and Getting Formula on Shelves," with Food and Drug Administration (FDA) Commissioner Dr. Robert Califf to examine the FDA's role in the ongoing infant formula shortage crisis. In his prepared opening remarks, Senator Richard Burr (R-NC), Ranking Member of the Senate HELP Committee, criticized the FDA for its failure and unwillingness to address pote… Continue Reading


05.23.22

Burr, Senators Call for Senate Appropriations Committee to Double CCDBG Funding in Five Years

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Committee on Health, Education, Labor and Pensions (HELP), along with Senators Susan Collins (R-ME), Lisa Murkowski (R-AK), John Cornyn (R-TX), and Todd Young (R-IN), sent a letter to the Senate Appropriations Committee's Subcommittee on Labor, Health, and Human Services (HHS), Education, and Related Agencies Chair Patty Murray (D-WA) and Ranking Member Roy Blunt (R-MO) urging the Subcommittee to prioritize Child Care and Developme… Continue Reading


05.20.22

Burr, Foxx Again Call Out Department of Education for Its Lack of Cooperation on Facebook Student Data Privacy Leak

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Committee on Health, Education, Labor and Pensions (HELP), and Representative Virginia Foxx (NC-05), Ranking Member of the House Committee on Education and Labor, sent a follow-up letter to U.S. Department of Education Secretary Miguel Cardona after the Department failed to respond to an initial requestdemanding accountability on the alarming breach of security and privacy violations of prospective college students. Today's letter … Continue Reading


05.19.22

Burr Releases Timeline Detailing FDA, Biden Admin Failures in Infant Formula Crisis

Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, today released a "timeline of failure" detailing the U.S. Food and Drug Administration's (FDA) and Biden Administration's role in creating the infant formula crisis. "I'm glad the Biden Administration is finally taking the infant formula crisis seriously, but their response is still too little, too late," Senator Burr said in a statement. "There were warning signs of an impending i… Continue Reading


05.18.22

Burr, Colleagues Introduce Bill to Stop President Biden from Canceling Student Loan Debt

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, along with Senators Mitt Romney (R-UT), Tim Scott (R-SC), Bill Cassidy, M.D. (R-LA), and Thom Tillis (R-NC) introduced the Student Loan Accountability Act, legislation to prohibit the Biden Administration from cancelling student loan debt at the expense of millions of Americans who chose to not go to college or worked diligently to pay off any student debt. Despite bipartisa… Continue Reading


05.18.22

Burr, Senators Submit Comment to Biden Labor Department Opposing Misleading Efforts to Rewrite Davis-Bacon

This week, Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, led a group of Senate colleagues in submitting comment to the U.S. Department of Labor opposing the Administration's proposal to make substantial, misguided, and burdensome changes to the wage regulations issued under the Davis-Bacon and Related Acts (DBRA). The comment, a response to the notice of proposed rulemaking (NPRM), is also signed by Senators Bill Cassidy (R-LA)… Continue Reading


05.17.22

Senators Burr, Murray Release Legislation to Support FDA Programs to Lower Costs and Spur Innovation

Today, Senate Health, Education, Labor and Pensions (HELP) Committee Ranking Member, Senator Richard Burr (R-NC), and Chair, Senator Patty Murray (D-WA), released a discussion draft of the FDA Safety and Landmark Advancements (FDASLA) Act-legislation reauthorizing the Food and Drug Administration's (FDA) prescription drug, generic drug, biosimilar, and medical device user fee agreements. The legislation also includes provisions to strengthen oversight of cosmetics and dietary supplements, modern… Continue Reading


05.16.22

Senator Burr Demands Accountability from FDA on Infant Formula Crisis

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Dr. Robert Califf demanding accountability from the FDA on its inaction to secure the nation's infant formula supply chain, following dire shortages across the country. In his letter, Senator Burr criticized FDA for its inability to mitigate the consequences of infant formula supply shortages, particularly … Continue Reading


05.12.22

Senator Burr Statement on Conference for U.S. Innovation and Competition Act of 2021

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions Committee, released the following statement on today's conference meeting for the United States Innovation and Competition Act of 2021: "China poses a unique competitive threat to America's economic security. The risk faced by our college campuses and research institutions, who have already seen the detrimental impact of China's aggressive posturing and disregard for intellectual property ri… Continue Reading


05.11.22

Burr Leads Letter Calling Out Brazen, Unilateral Attempt by IRS to Expand Obamacare Subsidies

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, along with Senator Pat Toomey (R-PA), Ranking Member of the Senate Banking, Housing and Urban Affairs Committee, and Senator Bill Cassidy, M.D. (R-LA) sent a letter to Internal Revenue Service (IRS) Commissioner Charles Rettig demanding clarity on its proposal to illegally expand the Affordable Care Act's premium tax credit (PTC), which would cost taxpayers billions more each … Continue Reading


05.10.22

Burr, Foxx Demand Accountability from Department of Education on Facebook Student Data Privacy Leak

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Committee on Health, Education, Labor and Pensions (HELP), and Representative Virginia Foxx (NC-05), Ranking Member of the House Committee on Education and Labor, sent a letter to Department of Education Secretary Miguel Cardona demanding accountability on the recently reported privacy violations of prospective college students across the country. On April 28, 2022, it was reported the Department of Education used Facebook's "Meta… Continue Reading


05.10.22

Burr, Foxx Demand Accountability from Department of Education on Facebook Student Data Privacy Leak

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Committee on Health, Education, Labor and Pensions (HELP), and Representative Virginia Foxx (NC-05), Ranking Member of the House Committee on Education and Labor, sent a letter to Department of Education Secretary Miguel Cardona demanding accountability on the recently reported privacy violations of prospective college students across the country. On April 28, 2022, it was reported the Department of Education used Facebook's "Meta… Continue Reading


05.10.22

Burr Questions Biden EEOC Nominee’s Lack of Impartiality, Commitment to Transparency

Today, the Senate Committee on Health, Education, Labor and Pensions (HELP) held a nomination hearing for Kalpana Kotagal to be a Member of the Equal Employment Opportunity Commission (EEOC). In his submitted statement for the record, Ranking Member Richard Burr (R-NC) expressed his concern on Ms. Kotagal's radical political ties, lack of impartiality, and unwillingness to commit to transparency that is critical to the Commission. Senator Burr's submitted statement for the record: "Senator Ri… Continue Reading


04.26.22

Burr: FDA Must Be Held Accountable to Meeting Terms of Its Commitments in User Fee Programs

Today, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing titled, "FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients, FDA Center Directors." This is the Committee's second hearing to examine the commitment letters submitted by the Food and Drug Administration (FDA) and industry leaders for the reauthorization of the prescription drug, generic drug, biosimilar, and medical device user fee agreements. The first he… Continue Reading


04.24.22

Senator Burr Statement on the Passing of Former Senator Orrin Hatch

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Committee on Health, Education, Labor and Pensions, today released the following statement on the passing of former U.S. Senator Orrin Hatch: "I am deeply saddened by the passing of Orrin Hatch. Orrin was a stalwart of the Senate and a true statesman. He believed in the importance of working across the aisle on common causes, but never compromised in his faith or his principles. It was a privilege to serve alongside and learn from… Continue Reading


04.06.22

Burr, Colleagues Press Education Secretary Cardona to Extend Public Comment Period on Troubling Charter School Proposals

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, along with Senators Bill Cassidy, M.D. (R-LA), Mike Braun (R-IN), Tim Scott (R-SC), John Cornyn (R-TX), and Marco Rubio (R-FL) sent a letter to Department of Education Secretary Miguel Cardona urging the Department to extend its 30-day public comment period following its recent and devastating decision to discourage Charter School Programs (CSP) from participating in federal g… Continue Reading


04.06.22

Senator Burr Blasts Biden Administration for Fourth Extension of Student Loan Repayment Freeze

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Health, Education, Labor and Pensions (HELP) Committee, released the following statement after the Biden Administration announced its four-month extension to the student loan repayment freeze, the fourth such extension under this Administration: "The Biden Administration wants to have their cake and eat it, too: they want to tout America's return to normal following the pandemic, but also want to keep extending emergency relief po… Continue Reading


04.05.22

Burr Presses CDC for Science Behind Title 42 Decision

Today, Senator Richard Burr (R-NC), Ranking Member of the Senate Committee on Health, Education, Labor and Pensions, sent a letter to Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky pressing the agency to clarify the science behind its decision to terminate the Title 42 order after apparent inconsistencies between the rationale used to support the decision and the current state of the ongoing response. "I believe that I understand the Administration's progressive pol… Continue Reading


04.05.22

Burr on FDA User Fee Agreements: Innovation is Key, When FDA Does Not Live Up to Commitments, Patients Suffer

Today, the Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing titled, "FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients." This is the Committee's first hearing to examine the commitment letters submitted by the Food and Drug Administration (FDA) and industry leaders earlier this year for the reauthorization of the prescription drug, generic drug, biosimilar, and medical device user fee agreements. Ranking Memb… Continue Reading

Showing page   of 7